
Opinion|Videos|March 31, 2025
Lp(a) Levels: A Continuous Relationship With ASCVD Levels and Consistent Throughout a Lifetime
Experts discuss the evidence supporting the continuous relationship between lipoprotein(a) (Lp[a]) levels and atherosclerotic cardiovascular disease (ASCVD), as recognized by the National Lipid Association, and explore how Lp(a) levels may change throughout a person’s lifetime or in response to lifestyle factors.
Advertisement
Video content above is prompted by the following:
- Historically, Lp(a) levels of at least 125 nmol/L (or 50 mg/dL) have been considered elevated. However, the National Lipid Association—or NLA—now recognizes the relationship between Lp(a) and ASCVD to be continuous. Could you speak to the evidence supporting this conclusion?
- How, if at all, do Lp(a) levels change throughout a person’s lifetime or in response to lifestyle factors?
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
OpenAI for Healthcare Aims to Streamline Clinical Workflows, Reduce Administrative Burden
2
Insights Into Patient Portal Engagement Leveraging Observational Electronic Health Data
3
Postpandemic Nursing Home Capacity Declines Tied to Longer Hospital Stays, Increased Patient Travel
4
Amivantamab Plus FOLFOX/FOLFIRI Demonstrates Strong, Durable Activity in mCRC
5




























































